Costly Med Devices Lying Idle In Hospitals Due To Infra, Manpower Crunch: CAG

Bhubaneswar:  Lack of infrastructure and manpower shortage are responsible for costly equipment and medical devices like ventilators and oxygen concentrators to lie idle or non-functional in several hospitals across the state, the CAG has observed.

According to the report tabled in the assembly, Odisha State Medical Corporation Limited (OSMCL) had supplied 402 ICU ventilators, worth around Rs 11.77 crore, to 13 private hospitals for treatment of Covid patients. After the pandemic, these ventilators were to be returned to the government.

“It was, however, noticed that these ventilators were not returned by the private hospitals. During inspection of 10 such hospitals, these ventilators were found to be lying in the stores of these private hospitals,” the CAG report stated.

It also said that OSMCL had supplied 817 Multipara monitors, costing nearly Rs 10.95 crore, to 12 private hospitals which were lying with them. The CAG found that 57 kinds of equipment received from OSMCL, National Health Mission (NHM) and PM Cares, were lying in the sub-stores of three district headquarters hospitals (DHH)s — Bhadrak, Dhenkanal and Sundargarh — without having been installed.

One laparoscopic unit, costing Rs 20.89 lakh, was lying idle at DHH, Puri, since March 2006 due to lack of trained technical staff. Similarly, one Remidio digital Fundus camera (Rs 4.97 lakh), that DHH, Nabarangpur had got in Nov 2021, was not put to use in the absence of an ophthalmologist and an ophthalmic assistant.

“Scrutiny of records and joint physical inspection of clinical and non-clinical departments of two surveyed medical colleges and hospitals (MCH) revealed that 553 items of equipment, costing Rs 17.76 crore, remained idle or defunct,” the report stated, without naming the healthcare institutions.

Related Posts

Gene Therapy for Cholesterol: Initial Test Results Cheer

Eli Lilly working on single-dose drug to be administered via IV for long-term gain Mumbai: For millions of heart patients struggling with elevated levels of cholesterol, there is a ray…

US Biotech Regeneron to launch Global Capability Centre in Hyderabad

Regeneron Pharmaceuticals, Inc. has announced plans to establish the Regeneron Global Capability Centre (GCC) in Hyderabad, a strategic investment that deepens its global operations and scales business functions to advance…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Gene Therapy for Cholesterol: Initial Test Results Cheer

Gene Therapy for Cholesterol: Initial Test Results Cheer

US Biotech Regeneron to launch Global Capability Centre in Hyderabad

US Biotech Regeneron to launch Global Capability Centre in Hyderabad

Popped the Pill, Paid the Price to Potentially Fatal Skin Syndrome

Popped the Pill, Paid the Price to Potentially Fatal Skin Syndrome

Former Advisor to India’s Union Health Ministry gets Quite a Feather in his Cap

Former Advisor to India’s Union Health Ministry gets Quite a Feather in his Cap

Alembic Pharma Secures USFDA Approval for Generic Synthroid Tablets

Alembic Pharma Secures USFDA Approval for Generic Synthroid Tablets

STF busts fake meds racket spread across 6 states

STF busts fake meds racket spread across 6 states